MeVis Medical Solutions AG (MMS), a subsidiary of Varex Imaging Corp, provides innovative software solutions designed for the analysis and evaluation of medical image data. The company’s clinical focus is centered on image-based early detection and diagnosis of a wide range of diseases, including breast, lung, liver, prostate, and colon cancer, as well as neurological diseases.

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.

MMS has limited in-house research capacity, with most of its workforce focused on software application development. To support its R&D efforts, the company collaborates with renowned research institutes, such as the Diagnostic Image Analysis Group at Radboud University Medical Center, Nijmegen, to acquire research results or commission new studies. MMS is focused on developing software solutions for new applications, including CT-based lung cancer screening and MR-based liver diagnostics. The company is also working on advancing artificial intelligence-driven algorithms for both medical and industrial uses.